Renal Function in Β-Thalassemia Major Receiving Desferal Versus Deferasirox

Journal of Renal Injury Prevention - Iran
doi 10.15171/jrip.2018.37
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Maad Rayan Publishing Company

Related search

Deferasirox (Exjade®) Significantly Improves Cardiac T2* in Heavily Iron-Overloaded Patients With Β-Thalassemia Major

Annals of Hematology
MedicineHematology
2009English

Psy56 - Cost-Utility of New Film-Coated Tablet Formulation of Deferasirox Versus Deferoxamine Among Major B-Thalassemia Patients in Iran

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pulmonary Function Tests in Β Thalassemia Major and Its Correlation With Serum Ferritin Levels

International Journal of Contemporary Pediatrics
2019English

PLASMA INHIBITOR OF PLATELET FUNCTION IN Β-Thalassemia

Pediatric Research
Child HealthPediatricsPerinatology
1977English

Creatinine Versus Cystatin C: Differing Estimates of Renal Function in Hospitalized Veterans Receiving Anticoagulants

Journal of General Internal Medicine
Internal Medicine
2018English

Β Globin Mutations in Turkish, Northern Iraqi and Albanian Patients With Β Thalassemia Major

Thalassemia Reports
2018English

Investigation of FoxO3 Dynamics During Erythroblast Development in Β-Thalassemia Major

PLoS ONE
Multidisciplinary
2017English

MRI Multicentre Prospective Survey in Thalassaemia Major Patients Treated With Deferasirox Versus Deferiprone and Desferrioxamine

British Journal of Haematology
Hematology
2018English

IF07. Early Renal Function Alterations in Renal Branches Versus Renal Fenestrations

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy